Table 2.
The mean (m), standard deviation (SD), and p values of the scores obtained from the SNOT-22 questionnaire
| CG | NSU | p* | |||
|---|---|---|---|---|---|
| m | SD | m | SD | ||
| Need to blow nose | 1.5 | 0.7 | .6 | 0.5 | < 0.001 |
| Nasal obstruction | 1.6 | 0.6 | 1.1 | 0.6 | 0.015 |
| Sneezing | 1.4 | 0.6 | .9 | 0.6 | 0.016 |
| Runny nose | 1.7 | 0.7 | 1.2 | 0.4 | 0.009 |
| Cough | 2.7 | 1.0 | 1.9 | 0.5 | 0.004 |
| Postnasal drip | 1.4 | 0.7 | 0.4 | 0.5 | < 0.001 |
| Thick nasal discharge | 1.5 | 0.8 | 0.4 | 0.5 | < 0.001 |
| Ear fullness | 0.5 | 0.5 | 0.6 | 0.5 | 0.613 |
| Dizziness | 0.8 | 0.4 | 0.8 | 0.4 | 0.764 |
| Ear pain | 0.2 | 0.4 | 0.1 | 0.3 | 0.341 |
| Facial pain and/or pressure | 2.2 | 1.0 | 0.9 | 0.3 | 0.011 |
| Loss of smell and taste | 4.2 | 1.0 | 3.1 | 1.3 | 0.001 |
| SNOT-22 Total | 19.6 | 3.1 | 11.9 | 1.7 | < 0.001 |
NSU nasal steroid use, CG control group
*Mann–Whitney U test